Cuidados clínicos na estratificação de risco e tratamento de pacientes com doença hepática gordurosa não alcoólica.

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology

Comunicado de imprensa: International experts develop Clinical Care Pathway in response to NASH epidemic – American Gastroenterology Association

Conteúdos relacionados:

Non-alcoholic fatty liver disease: A patient guideline.

State of the art review: Management of non-alcoholic fatty liver disease

M-A: Non-alcoholic fatty liver disease linked to increased risk of fatal and non-fatal cardiovascular events.

M-A: non-invasive tests for advanced fibrosis can reduce the need for biopsy in patients with non-alcoholic fatty liver disease.

Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.